Jennison Associates’s 10x Genomics TXG Stock Holding History

Jennison Associates’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.53M	Sell	39,861 -19,228	-33%	-$504K	﹤0.01%	466
2026 Q1	$1.25M	Sell	59,089 -7,880	-12%	-$158K	﹤0.01%	476
2025 Q4	$1.09M	Buy	66,969 +21,162	+46%	+$320K	﹤0.01%	492
2025 Q3	$535K	Buy	+45,807	New	+$597K	﹤0.01%	533
2022 Q1	–	Sell	-92,476	Closed	-$13.8M	–	707
2021 Q4	$13.8M	Sell	92,476 -1,974	-2%	-$302K	0.01%	415
2021 Q3	$13.8M	Sell	94,450 -235,170	-71%	-$40.4M	0.01%	413
2021 Q2	$64.5M	Sell	329,620 -80,398	-20%	-$14.6M	0.04%	179
2021 Q1	$74.2M	Sell	410,018 -34,591	-8%	-$5.97M	0.05%	163
2020 Q4	$63M	Buy	444,609 +93,554	+27%	+$13.6M	0.04%	169
2020 Q3	$43.8M	Buy	351,055 +23,543	+7%	+$2.47M	0.04%	206
2020 Q2	$29.3M	Buy	+327,512	New	+$25.5M	0.03%	241

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jennison Associates's TXG Position: Q2 2026 in Review

Jennison Associates reduced its 10x Genomics (TXG) stake by 33% in Q2 2026, selling an estimated $504K and leaving 39,861 shares worth $1.53M. The position accounts for ﹤0.01% of the portfolio, ranked #466.

Jennison Associates first reported a position in TXG in Q2 2020 and has held it in 11 quarters since. The position peaked at $74.2M in Q1 2021. 392 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

Jennison Associates held 39,861 shares of 10x Genomics worth $1.53M as of Q2 2026.
Jennison Associates sold 19,228 10x Genomics shares in Q2 2026, an estimated $504K.
10x Genomics made up ﹤0.01% of Jennison Associates's portfolio in Q2 2026, its #466 holding.
Jennison Associates first reported a position in 10x Genomics in Q2 2020 and has held it in 11 quarters since.
Jennison Associates's 10x Genomics position peaked at $74.2M in Q1 2021.
392 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Jennison Associates's 13F filing for Q2 2026, filed 3 Aug 2026.